ABILIFY

Abilify is a product designed to alleviate the symptoms of depression.

#SimilarOrganizations #Website #More

ABILIFY

Industry:
Health Care Medical

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.abilify.com

Status:
Active

Contact:
+1 (855) 427-7470

Technology used in webpage:
Pound Sterling Japanese Yen Apple Whitelist Amazon Oregon Region


Similar Organizations

symphonia-logo

SYMPHONIA

Symphonia

Official Site Inspections

http://www.abilify.com Semrush global rank: 782.52 K Semrush visits lastest month: 50.48 K

  • Host name: 104.16.68.57
  • IP address: 104.16.68.57
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Abilify"

Health Canada Approves Otsuka and Lundbeck's …

Jan 17, 2025 ABILIFY ASIMTUFII is the longest long-acting injectable (LAI) that may be used without the need to establish treatment adequacy with a shorter-acting LAI. ... The IAM is a charitable organization ...See details»

MEDICATION FACT SHEET Aripiprazole (ay ri PIP ray zole ... - NAMI

• Abilify o Tablet: 2 mg, 5mg, 10 mg, 15 mg, 20 mg, 30 mg • Abilify Asimtufii (aripiprazole) o Extended-release injectable suspension: 720 mg/2.4 mL, 960 mg/3.2 mL • Abilify MyCite® o …See details»

Health Canada Approves Long-Acting Injectable Treatment for ...

Jan 21, 2025 ABILIFY ASIMTUFII is the longest long-acting injectable (LAI) that may be used without the need to establish treatment adequacy with a shorter-acting LAI. ... The IAM is a …See details»

Details for: ABILIFY ASIMTUFII - Drug and Health Products Portal

Details for: ABILIFY ASIMTUFII. Share: New search. Product description. Product name: ABILIFY ASIMTUFII. Company name: OTSUKA PHARMACEUTICAL CO LTD. DIN: 02554569. Status: …See details»

Abilify Uses, Dosage, Side Effects, Warnings - Drugs.com

Aug 22, 2023 Abilify is also used in children at least 6 years old to treat Tourette's disorder and to treat symptoms related to autistic disorder (irritability, aggression, mood swings, temper …See details»

Abilify Settlement | MNP

If you are an ABILIFY® Class Member, and did not previously opt out of the Quebec class action, you may make a request to the Quebec Court to opt out of the Settlement by sending a notice …See details»

ABILIFY ASIMTUFII® (aripiprazole) Treatment

ABILIFY ASIMTUFII ® (aripiprazole) Sound is a once every-2- months maintenance treatment for bipolar I disorder and treatment for schizophrenia in adults. Work with your healthcare provider …See details»

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

Beyond 6 weeks. Therefore, the required length of adjunctive treatment with ABILIFY is unknown. When prescribed as an adjunct to antidepressants in the treatment of MDD, ABILIFY should …See details»

Settlement Approved in the Canadian ABILIFY® and ABILIFY

TORONTO and MONTREAL, March 17, 2025 /CNW/ - On December 23, 2024 and February 7, 2025 the Ontario Superior Court of Justice and the Superior Court of Québec (the "Courts") …See details»

CANADIAN ABILIFY® AND ABILIFY MAINTENA® CLASS ACTIONS …

• were prescribed and received injections of ABILIFY MAINTENA ® between . February 6, 2014 . and . December 16, 2016; and • by virtue of a personal relationship with an ABILIFY® Class …See details»

Aripiprazole: Uses, Dosage, Side Effects, Warnings - Drugs.com

Aug 26, 2024 The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to …See details»

Details for: ABILIFY - Drug and Health Products Portal

Summary Basis of Decision for Abilify: The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and …See details»

Health Canada Approves Otsuka and Lundbeck's (Pr)ABILIFY

Jan 17, 2025 ABILIFY ASIMTUFII is the longest long-acting injectable (LAI) that may be used without the need to establish treatment adequacy with a shorter-acting LAI. ... The IAM is a …See details»

Finding support and advocacy - ABILIFY ASIMTUFII

ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including: Increased risk of stroke and ministroke has been reported in clinical studies with oral aripiprazole of …See details»

Abilify Asimtufii Drug / Medicine Information - News-Medical.net

14 hours ago Abilify Asimtufii should only be given by a healthcare professional. Do not receive if you have ever had an allergic reaction to aripiprazole or any of the ingredients listed at the end …See details»

Aripiprazole (Abilify) - PsychDB

Jan 21, 2024 Abilify Maintena is an extended-release (also known as long-acting) injectable suspension available in 400 mg or 300 mg formulations, given once every 4 weeks. Requires …See details»

Abilify | Uses, Interactions, Dosage & Aripiprazole Warnings

Mar 12, 2025 Abilify is an antipsychotic medicine that doctors prescribe to treat mental health conditions like schizophrenia, bipolar disorder and clinical depression. ... Drugwatch.com's …See details»

Abilify: Depression Uses, Side Effects, Dosage - MedicineNet

Aug 29, 2023 Abilify is an antipsychotic medication used to treat psychoses such as schizophrenia, bipolar mania and mixed manic/depressive episodes, major depressive …See details»

Abilify injection side effects: Common, mild, and serious

Apr 4, 2025 Abilify Maintena has a boxed warning.A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Boxed warnings for Abilify …See details»

9 Side Effects of Abilify to Know - Verywell Health

Apr 16, 2025 Abilify (aripiprazole) is a prescription atypical (second-generation) antipsychotic that treats depression, schizophrenia, and bipolar disorder. It also treats irritability related to …See details»

linkstock.net © 2022. All rights reserved